-
Uncategorized2 months agoWomen have awaited a revolution in menopause. It hasn’t arrived.
Persistent barriers are still hindering drug development for a host of menopause symptoms. Read More
-
Uncategorized2 months agoOpinion: What public health can learn from the MAHA movement
I didn’t expect to find myself face to face with leaders and activists from the “Make America Healthy Again” movement in respectful dialogue, or to consider...
-
Uncategorized2 months ago
GSK CEO’s ‘scientific courage’ propels plans for medley of phase 3 trials for Hansoh-partnered ADC
When Fierce last caught up with GSK’s head of oncology R&D back in November, we were told to “stay tuned” for the pharma to publish its...
-
Uncategorized2 months agoCancer Drug Shortfalls Tied to How BET Inhibitors Hit BRD2 and BRD4 Differently
For more than a decade, BET inhibitors have been touted as one of cancer therapy’s most promising drug classes. The logic was straightforward: many tumors rely...
-
Uncategorized2 months agoSTAT+: Top health officials highlight efforts to make medical records more portable
Zac Jiwa, a federal Medicare official, delivered a eulogy of sorts at a Thursday Medicare event highlighting the successes of the Health Tech Ecosystem initiative. The...
-
Uncategorized2 months ago
BBB Access Route via Proteomic Vascular Mapping
A limiting feature of many neurological therapies is the ability of molecules to cross the blood-brain barrier (BBB) from the circulatory system. Since the BBB prevents...
-
Uncategorized2 months agoNew rules for CDC vaccine panel aim to address lawsuit, empower Kennedy’s allies
After a courtroom defeat, Trump administration health officials have revised the governing documents for a key federal vaccine panel to broaden its membership, increase its focus...
-
Uncategorized2 months agoInvivyd reveals plans to test an antibody drug against measles
The drug, which Invivyd sees as a potential treatment and “targeted alternative” for the vaccine-hesitant, comes as measles cases in the U.S. are reaching levels not...
-
Uncategorized2 months ago
FDA plans another safety study of abortion drug after court order
The FDA is again looking into the safety of the abortion drug mifepristone following a Louisiana court order and calls from Republican lawmakers to investigate the...
-
Uncategorized2 months ago
AbbVie suggests new interpretation of ‘patient’ is necessary in 340B lawsuit
AbbVie filed suit against the federal government on Wednesday over its interpretation of the word “patient” under the 340B federal drug discount program. The lawsuit is...
Beyond sunshine: Iberia’s biotech moment has arrived with developing capital networks
Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins
